Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 23;9(2):232–238. doi: 10.1002/acn3.51508

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

(A) Average time (minutes) of walking during BWSTT sessions over weeks 1–4 (2 visits per week), weeks 5–9 (2 visits per week), weeks 10–14 (once weekly), and during the two weekly follow‐ups (once weekly) at 4 weeks after cessation to determine carry over effects. (B) Average number of walking bouts during BWSTT sessions over weeks 1–4, 5–9, 10–14, and during the 2 weeks of follow‐up after cessation of training for 4 weeks. The total number of bouts per session was determined based on the ability to withstand orthostatic standing challenges. There was a threefold increase in the average number of bouts per session and a 33% increase in the duration of the session in weeks 10–14 compared to weeks 1–4. (C) Average minutes per bout over the course of training. The minutes per bout decreased by 69% over the course of 14 weeks and was maintained during the 2‐week follow‐up visits. This reflected the decrease in percentage of BWS as indicated in 3D. (D) The percentage of BWS provided by the suspension that ensured erect posture without buckling of the knees. The percentage of BWS decreased from 83% to 69% over the course of the initial 14 weeks. The percentage of BWS was maintained at 72% in the 2‐week follow‐up visits. (E) A 14.4% increase in SCES amplitude from 3.67 V (weeks 1–4) to 4.2 V (weeks 10–14). After 4 weeks of cessation of BWSTT, the SCES amplitude was increased to 5.5 V (43%) to maintain 72%BWS.